162 related articles for article (PubMed ID: 15905540)
1. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
[TBL] [Abstract][Full Text] [Related]
2. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM
J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142
[TBL] [Abstract][Full Text] [Related]
3. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
4. Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.
Marchbank KJ; Watson CC; Ritsema DF; Holers VM
J Immunol; 2000 Sep; 165(5):2354-61. PubMed ID: 10946257
[TBL] [Abstract][Full Text] [Related]
5. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
6. Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.
Twohig JP; Pappworth IY; Sivasankar B; Kulik L; Bull M; Holers VM; Wang EC; Marchbank KJ
Mol Immunol; 2009 Jun; 46(10):2002-13. PubMed ID: 19359041
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
[TBL] [Abstract][Full Text] [Related]
8. Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.
Twohig J; Kulik L; Haluszczak C; Reuter J; Rossbach A; Bull M; Holers VM; Marchbank KJ
Mol Immunol; 2007 Jul; 44(13):3434-44. PubMed ID: 17379312
[TBL] [Abstract][Full Text] [Related]
9. Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.
Donius LR; Handy JM; Weis JJ; Weis JH
J Immunol; 2013 Jul; 191(1):434-47. PubMed ID: 23733878
[TBL] [Abstract][Full Text] [Related]
10. Impaired affinity maturation in Cr2-/- mice is rescued by adjuvants without improvement in germinal center development.
Wu X; Jiang N; Fang YF; Xu C; Mao D; Singh J; Fu YX; Molina H
J Immunol; 2000 Sep; 165(6):3119-27. PubMed ID: 10975825
[TBL] [Abstract][Full Text] [Related]
11. Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas.
Bolduc A; Long E; Stapler D; Cascalho M; Tsubata T; Koni PA; Shimoda M
J Immunol; 2010 Jul; 185(1):220-30. PubMed ID: 20505142
[TBL] [Abstract][Full Text] [Related]
12. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c.
Chen Y; Perry D; Boackle SA; Sobel ES; Molina H; Croker BP; Morel L
J Immunol; 2005 Jul; 175(2):1080-9. PubMed ID: 16002709
[TBL] [Abstract][Full Text] [Related]
13. Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.
Pappworth IY; Hayes C; Dimmick J; Morgan BP; Holers VM; Marchbank KJ
Immunobiology; 2012 Feb; 217(2):147-57. PubMed ID: 21783272
[TBL] [Abstract][Full Text] [Related]
14. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.
Acevedo-Suárez CA; Hulbert C; Woodward EJ; Thomas JW
J Immunol; 2005 Jan; 174(2):827-33. PubMed ID: 15634904
[TBL] [Abstract][Full Text] [Related]
15. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
Molina H; Holers VM; Li B; Fung Y; Mariathasan S; Goellner J; Strauss-Schoenberger J; Karr RW; Chaplin DD
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3357-61. PubMed ID: 8622941
[TBL] [Abstract][Full Text] [Related]
16. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
Pappworth IY; Kulik L; Haluszczak C; Reuter JW; Holers VM; Marchbank KJ
Mol Immunol; 2009 Mar; 46(6):1042-9. PubMed ID: 19187965
[TBL] [Abstract][Full Text] [Related]
17. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
18. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
Chung JB; Wells AD; Adler S; Jacob A; Turka LA; Monroe JG
J Immunol; 2003 Aug; 171(4):1758-67. PubMed ID: 12902475
[TBL] [Abstract][Full Text] [Related]
19. IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors.
Getahun A; Dahlström J; Wernersson S; Heyman B
J Immunol; 2004 May; 172(9):5269-76. PubMed ID: 15100265
[TBL] [Abstract][Full Text] [Related]
20. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice.
Pozdnyakova O; Guttormsen HK; Lalani FN; Carroll MC; Kasper DL
J Immunol; 2003 Jan; 170(1):84-90. PubMed ID: 12496386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
